Thank you to our major corporate sponsors
The following sponsors supported the programs and services of the American Kidney Fund with generous contributions of $5,000 or more in 2020.
AstraZeneca Pharmaceuticals LP
Akebia Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc.
DaVita Healthcare Partners, Inc
FMC Renal Pharmaceuticals
Otsuka America Pharmaceutical Inc.
Alexion Pharmaceuticals, Inc.
Satellite Healthcare Inc
Truist Foundation - formerly Suntrust
Right Advisory LLC
American Society of Nephrology
Apellis Pharmaceuticals, Inc.
Biotechnology Innovation Organization (BIO)
ColorNet Printing & Graphics
Dime Community Bank
Federal Street Strategies LLC
Fresenius Medical Care
Institute for Advanced Clinical Trials for Children
Jaspan Schlesinger LLP
JPA Health Communications
King & Spalding LLP
Latham & Watkins
Mercury Public Affairs
National Renal Administrators Association
Northleaf Capital Partners
OPKO Health - Renal Division
Rockwell Medical Technologies Inc
Satter Investment Management
SPG Fiduciary Partners of Raymond James
Spherix Global Insights
SplitOak Strategies LLC
The Cooking Doc, LLC
The Meltzer Group NFP
- The total pharmaceutical revenue including donated product is $5,361,700
- The percentage of revenue from pharmaceutical companies is 1.59%
Note: Compliance with the U.S. Department of Health and Human Services Office of the Inspector General Opinion 97-1, under which the HIPP program operates, prohibits HIPP (Health Insurance Premium Program) donors to be included in this list.